Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Penicillamine-induced pemphigus].

P Kind1, G Goerz, E Gleichmann

  • 1Universitäts-Hautklinik Düsseldorf.

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|September 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases.

Immunology today·2014
Same author

Histocompatibility antigens and chemical reactivity in autoimmunity.

Immunology today·2014
Same author

Identification of mutations in the uroporphyrinogen III cosynthase gene in German patients with congenital erythropoietic porphyria.

Physiological research·2007
Same author

Nickel allergy versus nickel tolerance: can oral uptake of nickel protect from sensitization?

Journal of environmental monitoring : JEM·2005
Same author

[Tolerance induction towards nickel. From animal model to humans].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2004
Same author

Tolerance to nickel: oral nickel administration induces a high frequency of anergic T cells with persistent suppressor activity.

Journal of immunology (Baltimore, Md. : 1950)·2001
Same journal

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral infections of the skin].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral exanthems in children].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Erratum to: Digital health applications and data protection].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Virus-induced exanthems in returning travellers].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Venous ulcus cruris-Surgical treatment].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
See all related articles

D-Penicillamine treats Wilson's disease, cystinuria, and rheumatoid arthritis but can cause autoimmune diseases like pemphigus. This case highlights drug-induced autoimmune conditions and their management.

Area of Science:

  • Immunology
  • Pharmacology
  • Dermatology

Background:

  • D-Penicillamine is a chelating agent used to treat Wilson's disease, cystinuria, and rheumatoid arthritis.
  • Despite its therapeutic benefits, D-penicillamine is associated with various adverse side effects.
  • These side effects can manifest as autoimmune conditions, including myasthenia gravis, lupus-like disease, IgA deficiency, and pemphigus vulgaris.

Observation:

  • This report details a specific case of D-penicillamine-induced pemphigus vulgaris.
  • The presentation focuses on the clinical presentation of this drug-induced autoimmune blistering disease.

Findings:

  • D-Penicillamine can trigger a range of autoimmune diseases through complex immunological mechanisms.
  • Pemphigus vulgaris is a recognized, albeit less common, adverse effect of D-penicillamine therapy.

Related Experiment Videos

Implications:

  • Understanding the potential for D-penicillamine to induce autoimmune diseases is crucial for patient safety.
  • Early recognition and appropriate management are essential for patients developing D-penicillamine-induced conditions.
  • Further research into the pathogenesis of drug-induced autoimmunity can inform safer therapeutic strategies.